Who We Are

Bioinformatix designed and developed a patent-pending software program, Rx&You(TM), which is a cloud-based artificial intelligence platform that remotely monitors patient medication behavior in real-time across their whole regimen, and intervenes when appropriate to help solve medication non-adherence, and pharmacovigilance, and coordinates care across many providers to solve polypharmacy. It also creates large volumes of patient-generated data about medication treatment for Big Data analytics to provide major opportunities for maximizing treatment.

In addition, the platform helps pharmaceutical companies satisfy regulations in the US, Europe, and 27 American states that now require electronic reporting of adverse events.

For patients, this means having a reminder system for their whole medication regimen that is patient-centric, (e.g., mobile call vs. email vs. SMS text vs. direct messaging). Our patient-centric reminder system also allows patients to prioritize medications differently thereby improving access to the right type of intervention when they need it most.

For providers, this means illuminating a dark void of information to improve care quality. With Rx&You, quality improves because the provider knows in advance who is not adhering to their regimens on a dose-by-dose basis for every medication, when, and why. The provider literally goes from not knowing who, what, when, or why – to knowing all these things for every patient and medication in near real-time.

Payers benefit because they inure financial savings from cost prevention and containment. By decreasing non-adherence and adverse events, and coordinating care, treatment costs can be prevented from increasing, often by thousands of dollars per patient per year.

Videos

Our History

Picture

The Idea

September 2015

The 2 founders had a new idea to improve patient adherence to medications.

Picture

First Demo

February 2016

The first demo of the RX&You™ platform was given at Massachusetts General Hospital.

Picture

First Advisor

March 2016

Bioinformatix signed its first advisor from the health insurance sector.

Picture

Provisional Patent Filed

April 2016

The RX&You™ patents filed at the US Patent & Trademark Office by Fenwick & West.

Picture

Top 10 Insurance

July 2016

Began due diligence with first Top 10 insurance carrier.

Picture

COO named

August 2016

Bioinformatix appointed Jeffrey Weiss as its first Chief Operating Officer.

Picture

Additional Advisors

August 2016

Bioinformatix signs two additional advisors from the pharmaceutical and intellectual property sectors.

Picture

First Pharmaceutical Pilot

August 2016

RX&You™ Platform pilot invitation from top 10 pharmaceutical company.

Picture

First Research Hospital Pilot

September 2016

RX&You™ Platform pilot invitation from first medical research hospital.

Picture

Astellas C3Prize Finalist

September 2016

Bioinformatix was chosen as a top 5 finalist out of 120 entries for its RX&You™ platform.

Picture

Found by Press

September 2016

Eligible says RX&You™ 1 of 7 healthcare start-ups you should know.

Picture

World Tech Finalist

November 2016

RX&You™ chosen as 1 of 6 global finalists for WTN Award in health and medicine.

Picture

Startup Boot Camp China

May 2017

Bioinformatix chosen as the only U.S. digital health company for the inaugural cohort of start-ups.

Picture

First Roadshow

September 2017

Complete first technology road show in China presenting in 5 major cities.

Picture

International Makers Festival

September 2017

Guangzhou-Foshan 2017 International Makers Festival picks Rx&You to pitch.

Picture

AI+Pharma and Healthcare

October 2017

Rx&You™ presents at the 2017 AI+Pharma and Healthcare Innovation Summit.

Picture

City of Taizhou

November 2017

The city of Taizhou, China selects Rx&You™ to present.

Picture

Startup Festival 2017

December 2017

Bioinformatix presents on AI in Healthcare at Startup Festival 2017 in Seoul, South Korea.